Non-Hormonal Menopause Treatment Options Beyond Hormone Therapy and How to Choose

Non-hormonal menopause treatment includes prescription medicines, behavioral therapies, lifestyle measures, and symptom-support tools that do not use estrogen or progestogen. These options can be useful when hormone therapy is not preferred, is not a good fit, or simply does not address the symptom causing the most trouble. No single non-hormonal option works the same way for every menopause symptom. Something chosen for hot flashes may do little for ongoing insomnia, fatigue, anxiety, or vaginal discomfort, so it helps to start with the symptom you most want to change.

A better place to start is with the problem you want to change. Are hot flashes interrupting work? Are night sweats waking you? Is difficulty falling asleep continuing even on cooler nights? Is fatigue new enough to need a broader health review? This article explains the main non-hormonal pathways, the evidence behind them, and a practical way to choose what to discuss with a clinician. It is educational, not a substitute for individual medical care.

What Does Non-Hormonal Menopause Treatment Mean

Think of non-hormonal treatment as a menu of options, not one replacement for hormone therapy. It includes prescription medicines, behavioral treatments, everyday adjustments, and supportive tools that do not contain estrogen or progestogen. The quick decision question is not “Is this natural?” It is “Does this option have evidence for the symptom I want help with, and does it fit my health history?”

Non-hormonal does not automatically mean natural, mild, or risk-free. A prescription medicine can be non-hormonal, while a supplement can be natural but still have uncertain benefits, side effects, or interactions. For that reason, it is worth reviewing both prescriptions and supplements with a clinician or pharmacist rather than relying on the label alone.

Hot flashes and night sweats are called vasomotor symptoms. The non-hormonal medicines most often discussed for them include selected SSRIs or SNRIs, gabapentin, fezolinetant, and oxybutynin. Some are used off label, meaning a clinician may prescribe an approved medicine for a use that is not listed on its FDA label. Low-dose paroxetine, fezolinetant, and, since October 2025, elinzanetant have FDA approvals for moderate to severe vasomotor symptoms due to menopause. That tells you what they are approved to address: hot flashes and night sweats, not every menopause symptom. [1-3]

Behavioral treatments serve a different purpose. Cognitive behavioral therapy can help reduce the impact of vasomotor symptoms on daily life. If trouble sleeping keeps going even when the bedroom is cool and hot flashes are not the only trigger, CBT-I is a structured first-line treatment for chronic insomnia. A useful plan can include more than one approach, but each part should have a clear job.

Figure 1. Neuroendocrine changes and symptom domains during menopause. Reproduced unchanged from Giannini et al. (2021), Figure 1, under CC BY 4.0. Source: reference 7.

Why Some People Choose Options Beyond Hormone Therapy

People have different reasons for looking beyond hormone therapy. Some prefer not to use hormones. Some have a medical history, a current medication, or a risk profile that calls for a more individualized discussion. Others have one dominant concern, such as recurring hot flashes during presentations or repeated waking at night, and want a symptom-specific plan.

This is not a contest between hormone and non-hormonal care. Menopausal hormone therapy remains an effective option for vasomotor symptoms for many appropriate candidates. Non-hormonal care matters because it gives people additional evidence-based choices when hormones are not wanted, are not appropriate, or are not the whole answer. A useful clinical conversation weighs the symptom, medical history, current medicines, side effects, monitoring, preferences, and what success would look like. [1]

What Are the Main Types of Non-Hormonal Menopause Treatments

Prescription options for hot flashes and night sweats

Guidelines support several non-hormonal options for bothersome vasomotor symptoms. SSRIs and SNRIs can help some people. Gabapentin may be considered, particularly when night symptoms are prominent. Oxybutynin has more limited evidence and may not suit everyone because of its adverse-effect profile. These are not interchangeable choices: other medicines, blood pressure, liver or kidney function, mood history, and personal priorities can all change the discussion. [1]

Neurokinin receptor antagonists are a newer category. Fezolinetant is FDA-approved for moderate to severe vasomotor symptoms, but its label carries a boxed warning for hepatotoxicity and requires baseline and follow-up liver tests. Elinzanetant was FDA-approved in October 2025 for the same symptom category. Neither is a treatment for every menopause-related concern, and neither should be started from an online list without a prescriber reviewing the full context. [2,3]

Behavioral care and daily routines

Behavioral options are especially relevant when symptoms interact with sleep, stress, and coping. Menopause-specific cognitive behavioral therapy and clinical hypnosis are recommended in the 2023 Menopause Society statement for vasomotor symptoms. The goal may be fewer symptoms for some people, but it can also be less distress and less disruption when symptoms occur. [1]

For chronic insomnia, CBT-I deserves a separate mention. It is a multicomponent treatment that can include cognitive strategies, stimulus control, and carefully structured sleep scheduling. It is more than generic advice to avoid screens or drink less caffeine. The American Academy of Sleep Medicine recommends multicomponent CBT-I for adults with chronic insomnia and advises against using sleep hygiene as the sole treatment. [4]

Complementary approaches and supportive tools

Symptom tracking, breathable bedding, a predictable wind-down, relaxation practices, and movement may support daily comfort or help reveal triggers. Their role should be described accurately. A routine that makes bedtime calmer may support sleep opportunity, but it is not a cure for insomnia or a treatment for hot flashes. Evidence for supplements and herbal remedies is inconsistent, and “plant-based” does not automatically mean effective or safe. Bring all over-the-counter products into the same medication review as prescriptions. [1]

Which Approach May Fit Different Menopause Symptoms

A symptom-first framework prevents two common mistakes: expecting one intervention to solve every symptom and overlooking a problem that needs its own assessment. Use the table as a discussion guide, not as a prescription.

Table 1. A symptom-first discussion guide for non-hormonal menopause care.

For example, a person whose main concern is eight disruptive hot flashes a day may reasonably ask about treatments with evidence for vasomotor symptoms. Someone who wakes at 3 a.m. may need to sort out whether heat, insomnia, sleep apnea, pain, alcohol, mood, or another issue is doing the waking. The same label, “poor sleep,” can point to very different next steps.

A one- or two-week symptom record can make the conversation more precise. Note when episodes occur, what happened beforehand, how long they last, and how they affect the next day. Add sleep timing, caffeine or alcohol use, medicines and supplements, and any bleeding changes that seem relevant. This is not a diagnostic test. It is a practical way to replace a vague request for “something non-hormonal” with a clearer goal and a baseline for judging change.

How Sleep and Stress Regulation Fit Into Non-Hormonal Care

Menopause symptoms can interact in a loop. Night sweats may fragment sleep; poor sleep can make the next day feel harder; and a stressful evening can make settling down more difficult. This does not mean stress causes every hot flash, or that a relaxation practice can replace medical treatment. It means a complete plan can include both symptom-directed care and practical support for sleep and recovery. For more on the potential role of ear-based taVNS in menopause-related sleep and stress, read ZenoWell's guide to vagus nerve stimulation for menopause, which discusses the current evidence and its limitations.

Figure 2 illustrates a proposed relationship among vasomotor symptoms, sleep, and mood. It is a conceptual model, not proof that any single symptom causes every downstream effect. That distinction matters when interpreting wellness claims and when setting expectations for treatment. [8]

Figure 2. A proposed pathway linking vasomotor symptoms, altered sleep, and depressive symptoms. Reproduced unchanged from Cagnacci et al. (2025), Figure 1, under CC BY 4.0. This figure presents associations and hypotheses, not proof of causation. Source: reference 8.

Optional Wind-Down Support With ZenoWell

If the main challenge is winding down and protecting a planned bedtime,ZenoWell may be used as an optional non-drug relaxation support tool alongside a consistent evening routine. Its ear-based format can provide a repeatable cue to pause, lower stimulation, and transition away from demanding tasks. It does not treat menopause, reduce hot flashes, balance hormones, replace hormone therapy, or substitute for CBT-I or medical evaluation. Persistent insomnia, heavy snoring, gasping, or severe daytime sleepiness deserve clinical assessment.

Are Natural Remedies the Same as Non Hormonal Treatments

No. Natural remedies are only one subset of non-hormonal options. Nutrition, exercise, mind-body practices, supplements, and herbal products are often called natural. Prescription medicines such as paroxetine, fezolinetant, and elinzanetant are non-hormonal but are not natural remedies. The labels are not evidence grades.

It is reasonable to ask what evidence supports the exact outcome you want, what harms or interactions are known, and how product quality is controlled. Supplements can be particularly hard to evaluate because formulations vary. If you use a supplement, record the exact product and dose and share it with the clinician or pharmacist reviewing your care. Do not delay evaluation of severe symptoms because a product is sold without a prescription. [1]

How to Choose a Non Hormonal Menopause Treatment

Start by naming the main symptom and its impact. “I wake twice a night because of sweating” is more actionable than “menopause is making me miserable.” Next, ask whether the option has evidence for that outcome. A medicine that reduces hot flashes may improve sleep indirectly for some people, but it is not automatically a chronic-insomnia treatment. A relaxation routine may improve the transition into bed without treating a sleep disorder.

Then consider your context: current prescriptions and supplements, medical history, previous treatment response, cost and access, side-effect tolerance, and whether monitoring is required. For prescription options, ask how long a trial should last, what to watch for, when to contact the prescriber, and how success will be measured. Shared decision-making is not indecision; it is the process of choosing a reasonable option for the person and the symptom in front of you.

Finally, set a realistic aim. A useful plan may lower the frequency or burden of hot flashes, make sleep more reliable, or improve daytime function without making every symptom disappear. Be skeptical of claims that a single supplement, device, or protocol will “fix hormones” or work for everyone.

When to Talk With a Healthcare Professional

Talk with a clinician when symptoms affect work, sleep, relationships, or daily activities; when you are considering a prescription option; or when it is unclear whether the symptoms are menopause-related. Seek assessment for unusual bleeding, chest pain, fainting, severe shortness of breath, new neurologic symptoms, or rapidly worsening symptoms. A clinician can also check whether anemia, thyroid disease, medication effects, depression, sleep disorders, or another condition is contributing to fatigue, mood changes, or poor concentration.

Urgent mental-health symptoms, including thoughts of self-harm, need urgent local support. Menopause can be part of the picture, but it should not be used to explain away a serious new symptom.

Frequently Asked Questions

What is the newest non-hormonal menopause treatment?

In the United States, elinzanetant was FDA-approved in October 2025 for moderate to severe vasomotor symptoms due to menopause. Fezolinetant is another FDA-approved neurokinin-targeting option. Both are prescription medicines for hot flashes and night sweats, not general treatments for all menopause symptoms. [2,3]

What can I take instead of estrogen for menopause?

The answer depends on the symptom. Non-hormonal prescription options may help vasomotor symptoms; CBT-I may be appropriate for chronic insomnia; mood symptoms may need mental-health care or a medication discussion. A clinician can help match the approach to your health history and goals.

Are non-hormonal menopause treatments effective?

Some options have strong evidence for specific outcomes, especially vasomotor symptoms. Others have mixed or limited evidence. Effectiveness is most meaningful when the treatment, symptom, and expected benefit are clearly matched. [1]

Can menopause symptoms be managed naturally?

Lifestyle and mind-body practices can support coping, comfort, and sleep routines. Natural does not automatically mean proven, harmless, or appropriate for severe symptoms. Review supplements and herbal products with a clinician or pharmacist, especially if you take other medicines.

References

1. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590. doi:10.1097/GME.0000000000002200. Available from: https://doi.org/10.1097/GME.0000000000002200
2. U.S. Food and Drug Administration. VEOZAH (fezolinetant) tablets, for oral use: prescribing information. Revised December 2024. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216578s004lbl.pdf
3. U.S. Food and Drug Administration. Drug Trials Snapshots: LYNKUET (elinzanetant). Approved October 24, 2025. Available from: https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-lynkuet
4. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262. doi:10.5664/jcsm.8986.
5. Huang AJ, Faubion S, Grady D. Nonhormonal treatment of menopausal vasomotor symptoms. JAMA Intern Med. 2025;185(7):874-875. doi:10.1001/jamainternmed.2025.0990.
6. Crandall CJ, Mehta JM, Manson JE. Management of menopausal symptoms: a review. JAMA. 2023;329(5):405-420. doi:10.1001/jama.2022.24140.
7. Giannini A, Caretto M, Genazzani AR, Simoncini T. Neuroendocrine changes during menopausal transition. Endocrines. 2021;2(4):405-416. doi:10.3390/endocrines2040036. Figure 1 reproduced under CC BY 4.0.
8. Cagnacci A, Xholli A, Fiamberti M, Londero AP. Neurokinin antagonists to treat vasomotor symptoms—possible implications for long-term health and disease. J Clin Med. 2025;14(19):6852. doi:10.3390/jcm14196852. Figure 1 reproduced under CC BY 4.0.